Samorita Hospital Limited announcements
287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (16).
- Credit Rating Result
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the rating of the Company as "A3" in the long term along with Stable outlook based on audited financial statements up to June 30, 2025 and other relevant information up to the date of rating declaration.
- Resumption after Record Date
Trading of the shares of the company will resume on 13.11.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 12.11.2025.
- Qualified Opinion
The auditor of the company has given the "Qualified Opinion" paragraph in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/SAMORITA_2025.pdf
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 10.11.2025 to 11.11.2025 and trading of the shares will remain suspended on record date i.e., 12.11.2025.
- Dividend Declaration
The Board of Directors has recommended 5% Cash Dividend for the year ended June 30, 2025. Date of AGM: 09.12.2025, Time: 11:00 AM, Venue: Hybrid System, MH Samorita Hospital & Medical College, 117 Tejgaon, Love Road, Dhaka-1208. Record Date: 12.11.2025. The Company has also reported EPS of Tk. 0.62, NAV per share of Tk. 48.39 and NOCFPS of Tk. 1.72 for the year ended June 30, 2025 as against EPS of Tk. 0.56, NAV per share of Tk. 48.27 and NOCFPS of Tk. 2.04 for the year ended June 30, 2024.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (22.10.2025) following its corporate declaration.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.69 for July-September 2025 as against Tk. 0.25 for July-September 2024; NOCFPS was Tk. 1.61 for July-September 2025 as against Tk. 0.53 for July-September 2024. NAV per share was Tk. 49.08 as on September 30, 2025 and Tk. 48.39 as on June 30, 2025.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2025 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 21, 2025 at 07:00 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.30 for January-March 2025 as against Tk. 0.02 for January-March 2024; EPS was Tk. 0.90 for July 2024-March 2025 as against Tk. 0.92 for July 2023-March 2024. NOCFPS was Tk. 1.53 for July 2024-March 2025 as against Tk. 2.34 for July 2023-March 2024. NAV per share was Tk. 48.67 as on March 31, 2025 and Tk. 48.27 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2025 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.35 for October-December 2024 as against Tk. 0.06 for October-December 2023; EPS was Tk. 0.60 for July-December 2024 as against Tk. 0.90 for July-December 2023. NOCFPS was Tk. 1.50 for July-December 2024 as against Tk. 1.97 for July-December 2023. NAV per share was Tk. 48.38 as on December 31, 2024 and Tk. 48.27 as on June 30, 2024. Reasons of deviation in financial parameters: Operating results: (cont.) (cont. news of SAMORITA): Operating result in the reporting period has been significantly decreased due to the following reasons, compared to previous corresponding period: a. Revenue has been decreased. b. Cost of direct materials has been increased. c. Operating expenses to revenue has been increased. NOCFPS decreased from Tk. 1.97 to Tk.1.50 due to cash receipts from customers have been decreased and cash paid to suppliers & employees increased. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 25, 2025 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
- Sale confirmation of a Director
Ms. Shamsa Chowdhury, a director of the company, has further informed that she has completed its sale of 1,25,000 shares of the Company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 22.12.2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.